Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Safety of Discontinuing NSBBs in Cirrhotic Patients With Managed Primary Aetiological Factors	Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, digestive system disorder, esophageal disorder, esophageal varices, liver disorder, portal hypertension	Recruiting	Not stated	2025-08-22		NCT06549673

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Asian Institute of Gastroenterology, India	55
Changi General Hospital	29
Chinese University of Hong Kong	480
Institute of Liver and Biliary Sciences, India	53
National University Hospital, Singapore	120
Royal Prince Alfred Hospital, Sydney, Australia	10
Ruijin Hospital	454
Southern Medical University, China	37

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
AIG Hospital	Hyderabad	India	1
Changi General Hospital	Singapore	Singapore	16
Institute of Liver and Biliary Sciences	New Delhi	India	2
National University Hospital, Singapore	Singapore	Singapore	5
Prince of Wales Hospital	Hong Kong	Hong Kong	81
Royal Prince Alfred Hospital	Sydney	Australia	6
Ruijing Hospital	Shanghai	China	2
Southern Medical University	Guangzhou	China	1